Related Articles
Genetic alterations in lung adenocarcinoma with a micropapillary component
Responses to crizotinib and chemotherapy in patients with lung adenocarcinoma harboring a concomitant EGFR mutation and ALK gene rearrangement: A case report and review of the literature
Marked tumor response to crizotinib after 4 years of maintenance pemetrexed in a patient with anaplastic lymphoma kinase‑positive non‑small‑cell lung cancer
KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung
A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review